Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis

Status Completed

Clinical Trial Summary

OBJECTIVES: I. Assess the safety and effectiveness of budesonide in patients with primary sclerosing cholangitis or primary biliary cirrhosis experiencing a suboptimal response to ursodeoxycholic acid.

II. Estimate the efficacy of this therapy in these patient groups as a means of evaluating the feasibility of a long-term randomized trial.

Clinical Trial Description

PROTOCOL OUTLINE:

Patients receive budesonide by mouth 3 times daily for a minimum of 6 months. If liver biochemistries become normal, dosage is reduced to once daily. Treatment discontinues after 1 year. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00004842
Study type	Interventional
Source	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Contact
Status	Completed
Phase	Phase 1
Start date	May 1997
Completion date	April 1999

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02917408` - Retrospective Study About Primary Biliary Cholangitis During January 2001 to July 2016 at West China Hospital
Terminated	`NCT00550862` - Study of INT 747 in Combination With URSO in Patients With Primay Biliary Cirrhosis (PBC)	Phase 2
Completed	`NCT00004748` - Low-Dose Oral Methotrexate Versus Colchicine for Primary Biliary Cirrhosis	Phase 3
Completed	`NCT03630718` - Trial of Psychoeducational and Hypnosis Interventions on the Fatigue Associated With PBC in Women	N/A
Terminated	`NCT03633227` - Study of Obeticholic Acid (OCA) Evaluating Pharmacokinetics and Safety in Participants With Primary Biliary Cholangitis (PBC) and Hepatic Impairment	Phase 4
Terminated	`NCT00125281` - SAMe to Treat Biliary Cirrhosis Symptoms	Phase 2
Completed	`NCT04629456` - Physical Therapy for Liver Cirrhosis	N/A
Completed	`NCT03468699` - Autologous Bone Marrow Mononuclear Stem Cell for Children Suffering From Liver Cirrhosis Due to Biliary Atresia	Phase 2
Completed	`NCT00004784` - Phase III Randomized Study of Ursodiol With Vs Without Methotrexate for Primary Biliary Cirrhosis	Phase 3
Completed	`NCT00006168` - Ursodiol-Methotrexate for Primary Biliary Cirrhosis	Phase 3
Completed	`NCT00570765` - Study of INT-747 as Monotherapy in Participants With Primary Biliary Cirrhosis (PBC)	Phase 2
Recruiting	`NCT00160940` - Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis	N/A
Recruiting	`NCT03146910` - Swiss Primary Biliary Cholangitis Cohort Study
Terminated	`NCT03265249` - BRIDGE Device for Post-operative Pain Control	N/A
Terminated	`NCT02308111` - Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis	Phase 4
Recruiting	`NCT02936596` - Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome	N/A
Completed	`NCT00406237` - Pharmacokinetic Study Of Tigecycline In Adult Subjects With Primary Biliary Cirrhosis	Phase 1
Completed	`NCT04047160` - Safety, Tolerability of OP-724 in Patients With Primary Biliary Cholangitis (Phase I)	Phase 1
Recruiting	`NCT00145964` - Identification of the Genetic Variants Responsible for Primary Biliary Cirrhosis (PBC)	N/A
Terminated	`NCT03476993` - Non-comparative Study of BCD-085 in Combination With UDCA in Patients With Primary Biliary Cholangitis	Phase 2